BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 53 filers reported holding BCLS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,000 | -40.0% | 298 | -40.4% | 0.00% | – |
Q2 2022 | $5,000 | +150.0% | 500 | +99.2% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 251 | +151.0% | 0.00% | – |
Q4 2021 | $1,000 | -93.3% | 100 | -92.9% | 0.00% | – |
Q2 2021 | $15,000 | -6.2% | 1,401 | -4.9% | 0.00% | – |
Q1 2021 | $16,000 | -86.1% | 1,473 | -85.7% | 0.00% | – |
Q4 2020 | $115,000 | – | 10,313 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,263,000 | 3.47% |
Finepoint Capital LP | 603,429 | $5,950,000 | 1.52% |
Samsara BioCapital, LLC | 300,000 | $2,940,000 | 0.57% |
COMMODORE CAPITAL LP | 250,000 | $2,450,000 | 0.57% |
Bain Capital Life Sciences Investors, LLC | 487,500 | $4,778,000 | 0.38% |
Asymmetry Capital Management, L.P. | 71,372 | $699,000 | 0.37% |
First Trust Capital Management L.P. | 206,257 | $2,021,000 | 0.35% |
Exos Asset Management LLC | 68,672 | $673,000 | 0.35% |
Altium Capital Management LP | 100,000 | $980,000 | 0.27% |
SPHERA FUNDS MANAGEMENT LTD. | 216,250 | $2,132,000 | 0.23% |